eHealth Q2 Revenue Plunges 45% but Cash Flow Improves; Guidance Reaffirmed
EHTH is trading near its 52-week low of $1.197 (11% above the low).
Summary
eHealth reported a 45% revenue drop in Q2 2026 as it shifts to a Lifetime Advisory model, but operating cash flow improved to -$5M from -$41.2M. Full-year guidance was reiterated, with early signs of higher member engagement.
Key Events · Earnings and Guidance · EHTH
-
Revenue Plunges 45% on Strategic Shift
Q2 2026 total revenue fell to $33.6 million from $60.8 million a year ago, driven by lower Medicare enrollment as the company reduced variable marketing spend outside peak periods to focus on member engagement.
-
Operating Cash Flow Improves Sharply
Operating cash flow was -$5.0 million in Q2 2026, a $36.2 million improvement from -$41.2 million in Q2 2025, reflecting disciplined expense management and cost reduction initiatives.
-
Full-Year Guidance Reaffirmed
Management reiterated 2026 guidance: total revenue $405–$445 million, GAAP net income $8–$25 million, adjusted EBITDA $55–$75 million, and operating cash flow -$10 million to $12 million. Positive net adjustment revenue range narrowed to $16–$20 million.
-
Lifetime Advisory Model Shows Early Promise
Ancillary product cross-sell rates doubled year-over-year in Q2 2026, and key member engagement metrics improved, including higher email capture and response rates, validating the new operating model launched in April.
Analysis · EHTH · Finance
A deliberate pullback in marketing spend outside major enrollment periods, tied to the company's pivot to a Lifetime Advisory model, drove a steep 45% revenue decline to $33.6 million in the second quarter. While the GAAP net loss widened to $23.6 million, aggressive cost cuts dramatically improved operating cash flow to a $5 million burn from $41.2 million a year ago. Management's confidence in the strategy is underscored by reiterated full-year guidance for revenue of $405–$445 million and GAAP net income of $8–$25 million. Early signs from the new model are promising: ancillary cross-sell rates doubled, and member engagement metrics rose. Yet the near-term pain is real — Medicare segment revenue and gross profit both fell sharply, and tail revenue from prior enrollments dropped to $7.6 million from $17.8 million. The bet is that deeper advisor relationships will boost retention and lifetime value, but investors must weigh the cash flow improvement against the top-line deterioration.
How filings like this one have moved
In the 30 days to Oct 4, 2026, 29.1% of the 1568 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.60%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, EHTH was trading at $1.33 on NASDAQ in the Finance sector, with a market capitalization of approximately $45.1M. The 52-week trading range was $1.20 to $5.89. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.